As discussed above, the EGFR signaling pathway is deregulated in cancers, and EGFR and VEGF signaling has a major role in angiogenesis, tumor development, and metastasis, and dual inhibition of these signaling pathways is considered a potential strategy of lung cancer treatment (126). This evidence concerns the gene EGFR and cancer.